Hassan Fred

CIK 000111074412 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001110744

Recent Transactions

50 trades

Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-22+3,990→ 29,879 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2026-06-22+5,277→ 5,277 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2026-03-13+71,839→ 1,243,239 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2026-03-13−71,839→ 0 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2026-03-10+41,073→ 41,073 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2026-03-10+35,612→ 35,612 total
Award
PRECIGEN, INC.$PGEN
Common Stock
2026-03-10$3.51/sh+17,948→ 1,171,400 total
Award
Cocrystal Pharma, Inc.$COCP
Stock Options (Right to Buy)
2026-01-09+16,410→ 16,410 total
Award
EyePoint, Inc.$EYPT
Stock Option (Right to Buy)
2026-01-02+40,000→ 40,000 total
Award
Cocrystal Pharma, Inc.$COCP
Common Stock
2025-10-28$1.39/sh+359,713→ 1,383,009 total
Award
Cocrystal Pharma, Inc.$COCP
Warrants
2025-10-28$1.39/sh+719,426→ 719,426 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-20+6,589→ 25,889 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2025-03-14−87,412→ 0 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2025-03-14+87,412→ 1,153,452 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2025-03-13+71,839→ 71,839 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2025-03-13+83,517→ 83,517 total
Award
PRECIGEN, INC.$PGEN
Common Stock
2025-03-13$1.74/sh+36,206→ 1,066,040 total
Award
EyePoint, Inc.$EYPT
Stock Option (Right to Buy)
2025-01-03+40,000→ 40,000 total
Award
Cocrystal Pharma, Inc.$COCP
Common Stock
2024-10-09+8,067→ 1,023,296 total
Award
EyePoint, Inc.$EYPT
Stock Options (Right to buy)
2024-09-03+60,000→ 60,000 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2024-03-14+101,626→ 101,626 total
Award
PRECIGEN, INC.$PGEN
Common Stock
2024-03-14$1.43/sh+44,055→ 1,029,834 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2024-03-14+87,412→ 87,412 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2024-03-09−106,837→ 0 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2024-03-09+106,837→ 985,779 total
Purchase
PRECIGEN, INC.$PGEN
Common Stock
2023-08-14$1.75/sh+570,345→ 878,942 total
Award
Cocrystal Pharma, Inc.$COCP
Stock Options (Right to Buy)
2023-07-18+7,333→ 7,333 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−21,013→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Common Stock
2023-06-16−2,123→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−541→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−40,000→ 0 total
Award
Prometheus Biosciences, Inc.
Common Stock
2023-05-19+2,123→ 2,123 total
Award
PRECIGEN, INC.$PGEN
Common Stock
2023-03-09$1.17/sh+48,290→ 308,597 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-03-09+106,837→ 106,837 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2023-03-09+125,489→ 125,489 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-02-22−61,576→ 0 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2023-02-22+61,576→ 260,307 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2022-06-22+104,921→ 104,921 total
Award
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2022-05-19+21,013→ 21,013 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2022-03-25+16,212→ 198,731 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2022-03-25−16,212→ 0 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2022-02-22+83,189→ 83,189 total
Award
PRECIGEN, INC.$PGEN
Common Stock
2022-02-22$2.03/sh+27,832→ 182,519 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2022-02-22+61,576→ 61,576 total
Purchase
BridgeBio Pharma, Inc.$BBIO
Common Stock
2021-12-29$14.17/sh+19,300→ 19,300 total
Award
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2021-11-14+541→ 541 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2021-08-17+49,869→ 49,869 total

Hassan Fred

Recent Transactions

Companies

Recent Filings

Address